» Articles » PMID: 16775904

High Rates of HIV Testing Despite Low Perceived HIV Risk Among African-American Sexually Transmitted Disease Patients

Overview
Publisher Elsevier
Specialty General Medicine
Date 2006 Jun 17
PMID 16775904
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In the current diagnosis-based, human immunodeficiency virus (HIV) prevention climate, previous testing among persons at elevated HIV risk has cost and efficacy implications, as it signals continued behavioral risk, limited HIV knowledge or overuse of services. This study sought to determine the proportion of African Americans newly seeking sexually transmitted disease (STD) diagnosis who previously had obtained HIV counseling and testing.

Methods: This was a clinic-based, cross-sectional survey of African-American adults (N=408) seeking STO diagnosis at a public STD clinic located in a high-HIV and STD prevalence city in the U.S. south.

Main Findings: Eighty-four percent of respondents had previously obtained HIV counseling and testing: 68% had previously obtained care at the clinic. Sixty-five percent of respondents perceived themselves as having low or no HIV risk. Seventy-two percent correctly answered > or = 3 of 4 HIV knowledge items.

Conclusions: Although diagnosis-based HIV prevention initiatives promote HIV counseling and testing for both primary and secondary HIV prevention, these findings suggest that many African-American STD patients remain at risk following testing. Future research should explore how the counseling portion of standard HIV counseling and testing influences subsequent knowledge, attitudes, risk perceptions and behaviors.

Citing Articles

Cognitive dissonance as a reason for low perceived HIV risk among Black women.

Hill M Front Sociol. 2025; 9:1498383.

PMID: 39867998 PMC: 11758228. DOI: 10.3389/fsoc.2024.1498383.


Is racism a barrier to HIV care continuum engagement among Black People in the United States? A scoping review to assess the state of the science and inform a research agenda.

Ford C, Cook M, Cross R Epidemiol Rev. 2024; 46(1):1-18.

PMID: 39657202 PMC: 11647039. DOI: 10.1093/epirev/mxae005.


Associations Among HIV Risk Perception, Sexual Health Efficacy, and Intent to Use PrEP Among Women: An Application of the Risk Perception Attitude Framework.

Sewell W, Patel R, Blankenship S, Marcus J, Krakower D, Chan P AIDS Educ Prev. 2020; 32(5):392-402.

PMID: 33112674 PMC: 8049455. DOI: 10.1521/aeap.2020.32.5.392.


A Web-Based Intervention to Reduce Decision Conflict Regarding HIV Pre-Exposure Prophylaxis: Protocol for a Clinical Trial.

Nelson L, Ajiboye W, Djiadeu P, Odhiambo A, Pedersen C, Ramos S JMIR Res Protoc. 2020; 9(6):e15080.

PMID: 32348250 PMC: 7324994. DOI: 10.2196/15080.


Gender Differences in HIV Testing, Diagnosis, and Linkage to Care in Healthcare Settings: Identifying African American Women with HIV in Chicago.

Almirol E, McNulty M, Schmitt J, Eavou R, Taylor M, Tobin A AIDS Patient Care STDS. 2018; 32(10):399-407.

PMID: 30277816 PMC: 6909762. DOI: 10.1089/apc.2018.0066.


References
1.
Janssen R, Holtgrave D, Valdiserri R, Shepherd M, Gayle H, De Cock K . The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. Am J Public Health. 2001; 91(7):1019-24. PMC: 1446705. DOI: 10.2105/ajph.91.7.1019. View

2.
MacKellar D, Valleroy L, Secura G, Behel S, Bingham T, Celentano D . Unrecognized HIV infection, risk behaviors, and perceptions of risk among young men who have sex with men: opportunities for advancing HIV prevention in the third decade of HIV/AIDS. J Acquir Immune Defic Syndr. 2005; 38(5):603-14. DOI: 10.1097/01.qai.0000141481.48348.7e. View

3.
Mattson M . Impact of HIV test counseling on college students' sexual beliefs and behaviors. Am J Health Behav. 2002; 26(2):121-36. DOI: 10.5993/ajhb.26.2.5. View

4.
Exner T, Hoffman S, Parikh K, Leu C, Ehrhardt A . HIV counseling and testing: women's experiences and the perceived role of testing as a prevention strategy. Perspect Sex Reprod Health. 2002; 34(2):76-83. View

5.
. The economics of HIV in Africa. Lancet. 2002; 360(9326):1. View